Genetic testing has gone mainstream, with services like 23andMe capitalizing on our curiosity and selling genomic insights for a price.
And it’s no wonder, seeing as how information on everything—from how we respond to certain medications, to inherited risk factors—is stored in our DNA
Technavio analysts predict that the global genetic testing market (which includes all technology and techniques used to analyze DNA, RNA and protein) will grow at a CAGR of 9.65% from 2014-2019. Major segments like pharmacogenomics testing and predictive testing are expected to make significant contributions to the revenue of the overall market in the next few years.
Additionally, we’ve identified the top 15 companies expected to make waves in the genetic testing market through 2019.
Top 15 Vendors in the Global Genetic Testing Market
Abbott Laboratories
In an effort to help doctors determine how to best treat their patients, we have pioneered innovative ways to screen, diagnose and monitor a vast range of health conditions with greater speed, accuracy and efficiency. With the best information available, doctors can make treatment decisions faster. As a result, we have become a leading name in immunoassay diagnostics, blood screening, bedside testing and companion diagnostics.
AutoGenomics
Since the Company’s inception in 1999, scientists and engineers at AutoGenomics have endeavored to create automated technologies that simplify the complex test processes inherent in genetic analysis within a format that is user friendly and increases productivity in the clinical laboratory.
The INFINITI® system is designed specifically for processing AutoGenomics’ unique proprietary BioFilmChip® microarrays that can be multiplexed and configured with hundreds of biomarkers to assess disease signatures from a single sample specimen.
The INFINITI® system provides clinical laboratories with significant improvements in laboratory productivity, workflow and cost per reportable result.
Biocartis
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. The Company’s proprietary MDx Idylla™ platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. Idylla™ addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring.
Bio-Rad Laboratories
The Clinical Diagnostics Group develops, manufactures, sells, and supports a large portfolio of products for medical screening and diagnostics. Bio-Rad is a leading specialty diagnostics company and its products are recognized as the gold standard for diabetes monitoring and quality control systems. The group is also well known for its blood virus testing and detection, blood typing, autoimmune and genetic disorders testing, and internet-based software products. Bio-Rad’s clinical diagnostics products incorporate a broad range of technologies used to detect, identify, and quantify substances in bodily fluids and tissues. The results are used as aids to support medical diagnosis, detection, evaluation, and the monitoring and treatment of diseases and other medical conditions.
Cepheid
Our Mission: To enable molecular diagnostic testing of any patient specimen on a centralized or disseminated basis, thereby enabling medical providers to identify and treat diseases early, increasing opportunities to improve patients’ survival and quality of life.
EKF Diagnostics
The EKF range of analysers is unique in their ease of use, accuracy and portability which is why we are a trusted brand in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c.
EKF Diagnostics products’ reputation for quality, accuracy and ease of use stems from our beginnings as a technology business founded in Barleben in Germany in 1990. In the following years we have invested in developing a portfolio of analysers and consumables for the near patient care sector that deliver laboratory accuracy and reliability without the high costs and maintenance associated with lab devices.
Elitech Group
The ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents. By bringing together IVD specialty companies that offer innovative products and solutions, ELITechGroup has become a major contributor in advancing clinical diagnostics to laboratories in the proximity market, those operating closer to the patient.
The ELITechGroup manufactures and distributes diagnostic products for clinical chemistry, microbiology, immunology, and molecular biology though direct sales and a distribution network encompassing more than 100 countries.
IntegraGen
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on the Company’s technological expertise and scientific know how.
Interpace Diagnostics
Interpace Diagnostics provides full product commercialization and is working to develop and commercialize molecular diagnostic tests leveraging the latest technology and personalized medicine for better patient diagnosis and management.
Our unique approach allows molecular diagnostics companies the ability to bring their products to market in a more cost-effective and efficient, as well as faster, manner.
Myriad Genetics
Myriad strives to answer the most pressing questions a patient faces across major disease areas, including oncology, preventive care, urology, dermatology, autoimmune diseases and neuroscience. Our current product pipeline are focused on expanding our reach into these critical areas of healthcare where high value diagnostics can have a dramatic impact on loweing the burden of disease, increasing the quality of patient care and lowering the overall cost to the healthcare system.
Perkin Elmer
PerkinElmer is a global leader focused on improving the health and safety of people and the environment. Our dedicated team of 7,700 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues in human and environmental health. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain greater insights into their science to better protect our environment, our food supply and the health of our families.
Qiagen
QIAGEN is the world’s leading provider of innovative Sample & Assay Technologies, and a key player in the molecular biology revolution. More than one-half million customers throughout the world rely on the company’s products. QIAGEN’s sample technologies help to isolate genetic material and other molecules from biological samples such as blood, bone and tissue. These can then be analyzed using appropriate assay technologies to reveal the information concealed within. QIAGEN’s products transform raw bio- logical material into valuable molecular information according to standardized and reproducible procedures.
Quest Diagnostics
Quest Diagnostics is driven to discover and deliver diagnostic insights and innovations that help to improve human health. We offer a wide range of products and services that benefit patients, healthcare providers, and pharmaceutical medical device companies, life insurance companies and employers.
We are the world’s leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Our services range from routine blood tests — such as total cholesterol, Pap testing and white blood cell count — to complex, gene-based and molecular testing. We perform medical tests that aid in the diagnosis or detection of diseases, measure the progress or recovery from a disease or confirm that an individual is free from disease. We have specialized expertise in cancer, cardiovascular diseases, infectious diseases, and neurology. Read more about our
Roche Diagnostics
The world leader in in-vitro diagnostics, Roche Diagnostics offers genetic testing solutions focused on increasing medical value and testing efficiency, including automated PCR-based molecular diagnostics, target enrichment for next generation sequencing research, and IHC and ISH slide staining for anatomic pathology. The company’s personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients.
WaferGen Biosystems
WaferGen Biosystems, Inc. is an emerging leader in the development, manufacture, and sale of state-of-the-art systems for genome analysis for the life science and pharmaceutical industries. Based on collaborations established with leading research institutions, WaferGen believes that the SmartChip Real-Time PCR System is positioned as the platform of choice for biomarker identification and validation.
